Gyon Technologies Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,440
| Closed | -$388K | – | 632 |
|
|
2022
Q3 | $388K | Buy |
+15,440
| New | +$388K | 0.12% | 170 |
|
|
2022
Q1 | – | Sell |
-7,765
| Closed | -$205K | – | 635 |
|
|
2021
Q4 | $205K | Buy |
7,765
+3,012
| +63% | +$79.5K | 0.04% | 513 |
|
|
2021
Q3 | $478K | Buy |
+4,753
| New | +$478K | 0.13% | 207 |
|
|
2021
Q2 | – | Sell |
-20,288
| Closed | -$2.02M | – | 520 |
|
|
2021
Q1 | $2.02M | Buy |
20,288
+8,958
| +79% | +$893K | 0.88% | 15 |
|
|
2020
Q4 | $1.4M | Buy |
+11,330
| New | +$1.4M | 0.48% | 55 |
|